The Nicotinamide Mononucleotide (NMN) market covers Content ＜98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.
According to our (Global Info Research) latest study, the global Nicotinamide Mononucleotide (NMN) market size was valued at USD 260.1 million in 2022 and is forecast to a readjusted size of USD 493.2 million by 2029 with a CAGR of 9.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main global Nicotinamide Mononucleotide (NMN) players include GeneHarbor, Herbalmax, Shinkowa Pharmaceutical, EffePharm, etc. The top four Nicotinamide Mononucleotide (NMN) players account for approximately 83% of the total market. Asia-Pacific is the largest consumer market for Nicotinamide Mononucleotide (NMN), accounting for about 76%, followed by Europe and Americas. In terms of type, Content ≥98% is the largest segment, with a share over 99%. And in terms of application, the largest application is Health Care Products, followed by Cosmetics.
The downstream applications of nicotinamide mononucleotide include health care products and cosmetics. Health products are the largest application market. In 2019, health products accounted for 98% of the total downstream consumption of nicotinamide mononucleotide in global.
This report is a detailed and comprehensive analysis for global Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
For more information (Including Full TOC, List of Tables & Figures, Chart), please click @ https://www.globalinforesearch.com/reports/993635/nicotinamide-mononucleotide-(nmn)
This report profiles key players in the global Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical and Maac10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segment by Type
Content below 98%
Content above 98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-17665052062 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
No comments:
Post a Comment